Cardiol Therapeutics Inc.
CRDL
$1.38
$0.032.22%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.17M | -7.23M | -6.04M | -5.77M | -5.84M |
| Total Depreciation and Amortization | 18.60K | 18.60K | 18.40K | 17.40K | 34.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.86M | 2.64M | 2.25M | 878.40K | 1.10M |
| Change in Net Operating Assets | -452.40K | -451.70K | 485.20K | -105.80K | 707.50K |
| Cash from Operations | -3.75M | -5.03M | -3.29M | -4.98M | -4.00M |
| Capital Expenditure | -2.20K | -2.20K | -4.70K | -8.30K | -4.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.20K | -2.20K | -4.70K | -8.30K | -4.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.80K | -13.80K | -13.80K | -13.80K | -13.80K |
| Issuance of Common Stock | 16.04M | 0.00 | 34.30K | -- | 21.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -477.00K | -- | -- | -- | -2.65M |
| Cash from Financing | 11.15M | -10.10K | 14.80K | -9.60K | 13.35M |
| Foreign Exchange rate Adjustments | -376.20K | 268.10K | -405.50K | -75.10K | 1.15M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.03M | -4.77M | -3.68M | -5.08M | 10.50M |